Unknown

Dataset Information

0

National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.


ABSTRACT:

Objectives

An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level.

Design

A national cross-sectional survey.

Setting

A SARS-CoV-2 antibody testing programme offered across all NHS Trusts.

Participants

1.14 million NHS staff.

Intervention

SARS-CoV-2 antibody testing.

Primary and secondary outcome measures

SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community seroprevalence as determined by the COVID-19 Infection Survey (Office for National Statistics). We also explored seroprevalence trends by regional COVID-19 activity, using regional death rates as a proxy for COVID-19 'activity'.

Results

1 146 310 tests were undertaken on NHS staff between 26 May and 31 August 2020. 186 897 NHS tests were positive giving a seroconversion rate of 16.3% (95% CI 16.2% to 16.4%), in contrast to the national community seroconversion rate of 5.9% (95% CI 5.3% to 6.6%). There was significant geographical regional variation, which mirrored the trends seen in community prevalence rates. NHS staff were infected at a higher rate than the general population (OR 3.1, 95% CI 2.8 to 3.5). NHS seroconversion by regional death rate suggested a trend towards higher seroconversion rates in the areas with higher COVID-19 'activity'.

Conclusions

This is the first cross-sectional survey assessing the risk of COVID-19 disease in healthcare workers at a national level. It is the largest study of its kind. It suggests that NHS staff have a significantly higher rate of COVID-19 seroconversion compared with the general population in England, with regional variation across the country which matches the background population prevalence trends. There was also a trend towards higher seroconversion rates in areas which had experienced high COVID-19 clinical activity. This work has global significance in terms of the value of such a testing programme and contributing to the understanding of healthcare worker seroconversion at a national level.

SUBMITTER: Coltart CEM 

PROVIDER: S-EPMC8282419 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7519560 | biostudies-literature
| S-EPMC10729028 | biostudies-literature
| S-EPMC8483034 | biostudies-literature
| S-EPMC2884625 | biostudies-literature
| S-EPMC8361003 | biostudies-literature
| S-EPMC4743929 | biostudies-literature
| S-EPMC9212203 | biostudies-literature
| S-EPMC7888604 | biostudies-literature
| S-EPMC7544564 | biostudies-literature
| S-EPMC8179248 | biostudies-literature